TCEB2/HIF1A signaling axis promotes chemoresistance in ovarian cancer cells by enhancing glycolysis and angiogenesis

MLA

Zhuo Deng, et al. “TCEB2/HIF1A Signaling Axis Promotes Chemoresistance in Ovarian Cancer Cells by Enhancing Glycolysis and Angiogenesis.” European Journal of Medical Research, vol. 29, no. 1, Sept. 2024, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s40001-024-02050-9.

APA

Zhuo Deng, Bin Li, Wenzhi Wang, Wei Xia, Lu Zhang, Lihong Chen, & Wen Jin. (2024). TCEB2/HIF1A signaling axis promotes chemoresistance in ovarian cancer cells by enhancing glycolysis and angiogenesis. European Journal of Medical Research, 29(1), 1–12. https://doi.org/10.1186/s40001-024-02050-9

Chicago

Zhuo Deng, Bin Li, Wenzhi Wang, Wei Xia, Lu Zhang, Lihong Chen, and Wen Jin. 2024. “TCEB2/HIF1A Signaling Axis Promotes Chemoresistance in Ovarian Cancer Cells by Enhancing Glycolysis and Angiogenesis.” European Journal of Medical Research 29 (1): 1–12. doi:10.1186/s40001-024-02050-9.